GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotron Ltd (ASX:BIT) » Definitions » Additional Paid-In Capital

Biotron (ASX:BIT) Additional Paid-In Capital : A$0.00 Mil(As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Biotron Additional Paid-In Capital?



Biotron Additional Paid-In Capital Historical Data

The historical data trend for Biotron's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotron Additional Paid-In Capital Chart

Biotron Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Biotron Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Biotron Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Biotron Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Biotron's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotron (ASX:BIT) Business Description

Industry
Traded in Other Exchanges
Address
56 Delhi Road, Suite 3.3, North Ryde, Sydney, NSW, AUS, 2113
Biotron Ltd is a biotechnology company. It is engaged in the funding and management of intermediate and applied biotechnology research and development projects. Its antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. Geographically, it operates only in Australia through biotechnology segment.

Biotron (ASX:BIT) Headlines

From GuruFocus

BlackRock Multi-Sector Income Trust's Dividend Analysis

By GuruFocus Research 10-13-2023